Hospital-acquired and ventilator-associated pneumonia: What's new in diagnosis and treatment?

American Journal of Surgery

Volumn 186, Issue 5 SUPPL. 1, 2003, Pages 4-14

  Napolitano, Lena M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CAB 175; CAB 179; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CP 6679; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SILVER; STREPTOGRAMIN DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ABDOMINAL SURGERY; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASPIRATION; ATELECTASIS; BACTERIUM CULTURE; BRONCHOSCOPY; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DEVICE INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; DRUG EFFICACY; DRUG USE; ENDOTRACHEAL INTUBATION; ENDOTRACHEAL TUBE; FEVER; HOSPITAL INFECTION; HUMAN; HYGIENE; HYPOVENTILATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LEUKOCYTOSIS; LUNG INFILTRATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUTH HYGIENE; NASOGASTRIC TUBE; PATHOPHYSIOLOGY; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SIDE EFFECT; SPLINTING; THORAX SURGERY; VENTILATOR;

EID: 0346218203     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2003.10.002     Document Type: Conference Paper

References (61)

1. Rello J., Ollendorf D.A., Oster G., et al. VAP Outcomes Scientific Advisory Group epidemiology and outcomes of ventilator-associated pneumonia in a large US database . Chest. 122:2002;2115-2121.
2. Goldmann D.A., Weinstein R.A., Wenzel R.P., et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistent microorganisms in hospitals a challenge to hospital leadership . JAMA. 275:1996;234-240.
3. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in medical intensive care units in the United States National Nosocomial Infections Surveillance System . Crit Care Med. 27:1999;887-892.
4. Vincent J.L., Bihari D.J., Suter P.M., et al. The prevalence of nosocomial infection in intensive care units in Europe results of the European Prevalence of Infection in Intensive Care (EPIC) study. EPIC International Advisory Committee . JAMA. 274:1995;639-644.
5. Fridkin S.K., Welbel S.F., Weinstein R.A. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am. 11:1997;479-496.
6. Croce M.A., Fabian T.C., Waddle-Smith L., Maxwell R.A. Identification of early predictors for post-traumatic pneumonia. Am Surg. 67:2001;105-110.
7. Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Recomm Rep 1997;46:1-79.
8. Garrard C.S., A'Court C.D. The diagnosis of pneumonia in the critically ill. Chest. 108:(suppl):1995;17S-25S.
9. National Nosocomial Infection Surveillance, Centers for Disease Control and Prevention. NNIS System Report, data summary from January 1992-June 2001; issued August 2001. Available at: www.cdc.gov/ncidod/hip/NNIS/members/ 2001NNIS_report.pdf.
10. Polk H.C. Jr, Mizuguchi N.N. Multifactorial analyses in the diagnosis of pneumonia arising in the surgical intensive care unit. Am J Surg. 179:(suppl 1):2000;31-35.
11. Polk H.C. Jr, Heinzelmann M., Mercer-Jones M.A., Malangoni M.A., Cheadle W.G. Pneumonia in the surgical patient. Curr Probl Surg. 34:1997;117-200.
12. Croce M.A. Diagnosis of acute respiratory distress syndrome and differentiation from ventilator-associated pneumonia. Am J Surg. 179:(suppl 1):2000;26-29.
13. Croce M.A. Postoperative pneumonia. Am Surg. 66:2000;133-137.
14. Croce M.A., Fabian T.C., Waddle-Smith L., et al. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia a prospective study . Ann Surg. 227:1998;743-755.
15. Fagon J.Y., Chastre J., Wolff M., et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia a randomized trial . Ann Intern Med. 132:2000;621-630.
16. Arora S.C., Mudaliar Y.M., Lee C., Mitchell D., Iredel J., Lazarus R. Non-bronchoscopic bronchoalveolar lavage in the microbiological diagnosis of pneumonia in mechanically ventilated patients. Anaesth Intensive Care. 30:2002;11-20.
17. National Nosocomial Infection Surveillance, Centers for Disease Control and Prevention. NNIS Pneumonia Pilot Study. Available at: www.cdc.gov/ncidod/ hip/NNIS/members/pneumonia/pneumonia.htm.
18. Hospital-acquired pneumonia in adults diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies . Am J Respir Crit Care Med. 153:1995;1711-1725.
19. Ibrahim E.H., Ward S., Sherman G., Kollef M.H. A comparative analysis of patients with early-onset vs. late-onset nosocomial pneumonia in the ICU setting. Chest. 117:2000;1434-1442.
20. Iwahara T., Ichiyama S., Nada T., Shimokata K., Nakashima N. Clinical and epidemiologic investigations of nosocomial pulmonary infections caused by methicillin-resistant Staphylococcus aureus. Chest. 105:1994;826-831.
21. Rello J., Torres A., Ricart M., et al. Ventilator-associated pneumonia by Staphylococcus aureus comparison of methicillin-resistant and methicillin-sensitive episodes . Am J Respir Crit Care Med. 150:1994;1545-1549.
22. Gonzalez C., Rubio M., Romero-Vivas J., Gonzalez M., Picazo J.J. Bacteremic pneumonia due to Staphylococcus aureus a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms . Clin Infect Dis. 29:1999;1171-1177.
23. Hershow R.C., Khayr W.F., Smith N.L. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol. 13:1992;587-593.
24. Lucet J.C., Chevret S., Durand-Zaleski I., Chastang C., Regnier B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit results of a multicenter study . Arch Intern Med. 163:2003;181-188.
25. Huang S.S., Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 36:2003;281-285.
26. Jensen A.G., Jensen A.G., Wachmann C.H., et al. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med. 159:1999;1437-1444.
27. Graffunder E.M., Venezia R.A. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother. 49:2002;999-1005.
28. Fridkin S.K., Gaynes R.P. Antimicrobial resistance in intensive care units. Clin Chest Med. 20:1999;303-316.
29. Trouillet J.L., Chastre J., Vuagnat A., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 157:1998;531-539.
30. Francois P., Pittet D., Bento M., et al. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol. 41:2003;254-260.
31. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 118:2000;146-155.
32. Leibovici L., Shraga I., Driucker M., Konigsberger H., Samra Z., Pitlik S.D. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infections. J Intern Med. 244:1998;379-386.
33. Luna C.M., Vujacich P., Niederman M.S., et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 111:1997;676-685.
34. Alvarez-Lerma F. Modification of empiric antibioitic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med. 22:1996;387-394.
35. Rello J., Gellego M., Mariscal D., Sonora R., Valles J. The value of routine microbiologic investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 156:1997;196-200.
36. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001;27:355-362.
37. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections a risk factor for hospital mortality among critically ill patients . Chest. 115:1999;462-474.
38. Kollef M.H. Inadequate antimicrobial treatment an important determinant of outcome for hospitalized patients . Clin Infect Dis. 31:(suppl 4):2000;S131-S138.
39. Ibrahim E.H., Ward S., Sherman G., Schaiff R., Fraser V.J., Kollef M.H. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med. 29:2001;1109-1115.
40. Fagon J., Patrick H., Haas D.W., et al. Treatment of gram-positive nosocomial pneumonia prospective randomized comparison of quinupristin/ dalfopristin versus vancomycin . Am J Respir Crit Care Med. 161:2000;753-762.
41. Rubinstein E, Cammarata S, Oliphant T, Wunderink R, for the Linezolid Nosocomial Pneumonia Study Group. Linezolid (PNU-10076) versus vancomycin in the treatment of hospitalized patients with nosocominal pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 2001;32:402-412.
42. Cruciani M., Gatti G., Lazzarini L., et al. Penetration of vancomycin into human lung tissue. J Antimicrob Chemother. 38:1996;865-869.
43. Conte J.E. Jr, Golden J.A., Kipps J., Zurlinden E. Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother. 46:2002;1475-1480.
44. Kollef M., Croos-Dabrera R.V., Cammarata S.K., Wunderink R. Linezolid vs vancomycin predictors of outcome in ventilator-associated nosocomial pneumonia [abstract] . Chest. 122:(suppl):2002;33S.
45. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003;124:1789-1797.
46. Luna C.M., Blanzaco D., Miederman M.S., et al. Resolution of ventilator-associated pneumonia prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome . Crit Care Med. 31:2003;676-682.
47. Ibrahim E.H., Kollef M.H. Using protocols to improve the outcomes of mechanically ventilated patients focus on weaning and sedation . Crit Care Clin. 17:2001;989-1001.
48. Ely E.W., Meade M.O., Haponik E.F., et al. Mechanical ventilator weaning protocols driven by nonphysician health-care professionals evidence-based clinical practice guidelines . Chest. 120:(suppl):2001;454S-463S.
49. Cook D.J., Meade M.O., Hand L.E., McMullin J.P. Toward understanding evidence uptake semirecumbency for pneumonia prevention . Crit Care Med. 30:2002;1472-1477.
50. Drakulovic M.B., Torres A., Bauer T.T., Nicolas J.M., Nogue S., Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients a randomized trial . Lancet. 354:1999;1851-1858.
51. Valles J., Artigas A., Rello J., et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med. 122:1995;179-186.
52. Mahul P., Auboyer C., Jospe R., et al. Prevention of nosocomial pneumonia in intubated patients respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis . Intensive Care Med. 18:1992;20-25.
53. Kollef M.H., Skubas N.J., Sundt T.M. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest. 116:1999;1339-1346.
54. Smulders K., van der Hoeven H., Weers-Pothoff I., Vandenbroucke-Grauls C. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest. 12:2002;858-862.
55. DeRiso A.J. II, Ladowski J.S., Dillon T.A., Justice J.W., Peterson A.C. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest. 109:1996;1556-1561.
56. Genuit T., Bochicchio G., Napolitano L.M., Roghman M.C. Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect. 2:2001;5-18.
57. Bellm L., Lehrer R.I., Ganz T. Protegrins new antibiotics of mammalian origin . Expert Opin Investig Drugs. 9:2000;1731-1742.
58. Olson M.E., Harmon B.G., Kollef M.H. Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest. 121:2002;863-870.
59. Sinuff T., Cook D.J. Health technology assessment in the ICU noninvasive positive pressure ventilation for acute respiratory failure . J Crit Care. 18:2003;59-67.
60. Zack J.E., Garrison T., Trovillion E., et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med. 30:2002;2407-2412.
61. CDC and the Healthcare Infection Control Practices Advisory Committee. Draft Guideline for the Prevention of Healthcare-Associated Pneumonia 2002. Available at: www.cdc.gov/ncidod/hip/pnguide.htm.